How to Discontinue Losartan
Losartan can be stopped abruptly without tapering in most clinical situations. Unlike some cardiovascular medications (such as beta-blockers), angiotensin receptor blockers (ARBs) like losartan do not require gradual dose reduction when discontinuing therapy.
Key Principles for Discontinuation
Abrupt Cessation is Safe
The FDA-approved prescribing information for losartan does not specify any tapering protocol for discontinuation 1. ARBs do not cause withdrawal phenomena or rebound hypertension when stopped suddenly, which distinguishes them from medications that require gradual weaning.
Clinical Context Matters
Before stopping losartan, you must have a clear clinical rationale and plan:
If switching to another antihypertensive: You can stop losartan and start the alternative agent on the same day. For example, if switching to an ACE inhibitor due to cost considerations, simply discontinue losartan and begin the ACE inhibitor without overlap 2.
If stopping due to adverse effects: Discontinue immediately. Common reasons include hyperkalemia, acute kidney injury, hypotension, or allergic reactions 1.
If the indication no longer exists: Stop the medication, but ensure appropriate blood pressure monitoring afterward.
Important Safety Considerations
Monitor After Discontinuation
While tapering is unnecessary, you should:
- Check blood pressure within 1-2 weeks after stopping to ensure adequate control if the patient has hypertension
- Monitor renal function and potassium within 1-2 weeks if the patient had baseline kidney disease or was on other medications affecting potassium 1
- Assess for disease progression if losartan was being used for diabetic nephropathy or heart failure
Special Populations Requiring Caution
Patients with heart failure: If losartan was prescribed for heart failure with reduced ejection fraction, stopping it abruptly is medically safe from a withdrawal standpoint, but you must have an alternative renin-angiotensin system blocker in place, as these medications reduce mortality 3, 4. Simply stopping without replacement would be inappropriate unless there's a compelling contraindication.
Patients with diabetic nephropathy: Losartan slows progression of kidney disease in type 2 diabetes 5. Stopping it requires either switching to another ARB or ACE inhibitor, or accepting potential loss of renoprotection.
Pregnant patients: Discontinue losartan immediately upon pregnancy detection due to fetal toxicity risk 1. No tapering is needed—immediate cessation is the priority.
Common Pitfalls to Avoid
- Don't confuse ARBs with beta-blockers: Beta-blockers require tapering to avoid rebound tachycardia and hypertension. ARBs do not.
- Don't leave patients unprotected: If losartan was treating a condition with mortality benefit (heart failure, post-MI with LV dysfunction), ensure an alternative medication is prescribed 6, 7.
- Don't forget volume status: Patients on losartan plus diuretics may experience blood pressure changes after stopping; adjust diuretic doses if needed 1.
Practical Algorithm
- Identify reason for discontinuation (side effect, drug interaction, pregnancy, switching agents, or indication resolved)
- Stop losartan immediately—no dose reduction needed
- If switching medications: Start replacement on the same day
- If stopping without replacement: Schedule blood pressure check within 1-2 weeks
- Monitor renal function and potassium within 1-2 weeks if patient has kidney disease or heart failure
The evidence consistently shows that ARBs do not require tapering protocols, making losartan straightforward to discontinue when clinically appropriate.